Digna Biotech, Genetrix Group deal

Digna and Genetrix's Biotherapix unit partnered to develop compounds to treat pulmonary fibrosis. The companies plan to combine Biotherapix's M3 protein, which inhibits chemokines, with Digna's P17 pe...